Refractory pruritus responds to dupilumab in a patient with TTC7A mutation

Yassaman Alipour Tehrany; Louis Marois; Caroline Colmant; Valérie Marchand; Victor Kokta; Jérôme Coulombe; Danielle Marcoux; Elie Haddad; Catherine McCuaig

doi:10.1016/j.jdcr.2020.12.004

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation

JAAD Case Rep. 2020 Dec 10:8:9-12. doi: 10.1016/j.jdcr.2020.12.004. eCollection 2021 Feb.

Authors

Yassaman Alipour Tehrany¹, Louis Marois², Caroline Colmant¹, Valérie Marchand³, Victor Kokta⁴, Jérôme Coulombe¹, Danielle Marcoux¹, Elie Haddad², Catherine McCuaig¹

Affiliations

¹ Division of Dermatology, Centre Hospitalier Universitaire Ste-Justine, Montréal, Québec, Canada.
² Division of Immunology, Centre Hospitalier Universitaire Ste-Justine, Montréal, Québec, Canada.
³ Division of Gastroenterology, Department of Pediatrics, Centre Hospitalier Universitaire Ste-Justine, Montréal, Québec, Canada.
⁴ Department of Pathology, Centre Hospitalier Universitaire Ste-Justine, Montréal, Québec, Canada.

No abstract available

Keywords: IL, interleukin; MIA, multiple intestinal atresia; TTC7A mutation; TTC7A, tetratricopeptide repeat domain 7A; chronic pruritus; combined immune deficiency; dupilumab; eczematous lesions; ichthyosis; multiple intestinal atresia; xerosis.

Publication types

Case Reports